DE69939707D1 - Varianten der humanen glycosylphosphatidylinositol-spezifischen phospholipase d und ihre verwendungen - Google Patents

Varianten der humanen glycosylphosphatidylinositol-spezifischen phospholipase d und ihre verwendungen

Info

Publication number
DE69939707D1
DE69939707D1 DE69939707T DE69939707T DE69939707D1 DE 69939707 D1 DE69939707 D1 DE 69939707D1 DE 69939707 T DE69939707 T DE 69939707T DE 69939707 T DE69939707 T DE 69939707T DE 69939707 D1 DE69939707 D1 DE 69939707D1
Authority
DE
Germany
Prior art keywords
pld
gpi
specific phospholipase
variants
diabetes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69939707T
Other languages
English (en)
Inventor
Julian Schofield
Thomas William Rademacher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sylus Pharmaceuticals Ltd
Original Assignee
Sylus Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9828715.4A external-priority patent/GB9828715D0/en
Priority claimed from GBGB9828713.9A external-priority patent/GB9828713D0/en
Priority claimed from GBGB9828712.1A external-priority patent/GB9828712D0/en
Application filed by Sylus Pharmaceuticals Ltd filed Critical Sylus Pharmaceuticals Ltd
Application granted granted Critical
Publication of DE69939707D1 publication Critical patent/DE69939707D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C12N9/20—Triglyceride splitting, e.g. by means of lipase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Obesity (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Emergency Medicine (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
DE69939707T 1998-12-24 1999-12-23 Varianten der humanen glycosylphosphatidylinositol-spezifischen phospholipase d und ihre verwendungen Expired - Fee Related DE69939707D1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9828715.4A GB9828715D0 (en) 1998-12-24 1998-12-24 Glycosylphosphatidylinositol specific phospholipase d protiens and uses thereof
GBGB9828713.9A GB9828713D0 (en) 1998-12-24 1998-12-24 Glycosylphosphatidylinositol specific phospholipase d protiens and uses therof
GBGB9828712.1A GB9828712D0 (en) 1998-12-24 1998-12-24 Glycosylphosphatidylinositol specific phospholipase d proteins and usues thereof
PCT/GB1999/004399 WO2000039285A2 (en) 1998-12-24 1999-12-23 Human glycosylphosphatidylinositol specific phospholipase d variants and uses thereof

Publications (1)

Publication Number Publication Date
DE69939707D1 true DE69939707D1 (de) 2008-11-20

Family

ID=27269604

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69939707T Expired - Fee Related DE69939707D1 (de) 1998-12-24 1999-12-23 Varianten der humanen glycosylphosphatidylinositol-spezifischen phospholipase d und ihre verwendungen

Country Status (7)

Country Link
EP (1) EP1141334B1 (de)
JP (1) JP2002533119A (de)
AT (1) ATE410516T1 (de)
AU (1) AU774986B2 (de)
CA (1) CA2355468A1 (de)
DE (1) DE69939707D1 (de)
WO (1) WO2000039285A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0015625D0 (en) * 2000-06-26 2000-08-16 Univ London Materials and methods relating for the treatment and diagnosis of pre-eclampsia
GB0015986D0 (en) * 2000-06-29 2000-08-23 Univ London Glycosylphosphatidylinositol specific phospholipase d proteins or the treatment or diagnosis of atherosclerosis
JP2007525952A (ja) * 2003-06-04 2007-09-13 デューク・ユニバーシティ Ｓ−ニトロソグルタチオンレダクターゼを調節するための組成物および方法
CA2906540C (en) * 2013-03-15 2021-01-12 Amgen Inc. Method of treating metabolic disorders using pla2g12a polypeptides and pla2g12a mutant polypeptides

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0477739A3 (en) * 1990-09-27 1992-12-09 F. Hoffmann-La Roche Ag Glycosyl-phosphatidylinositol-specific phospholipase d
EP1062246A1 (de) * 1998-03-18 2000-12-27 Rademacher Group Limited Anti-inositolphosphoglycan monoklonale antikörper

Also Published As

Publication number Publication date
AU774986B2 (en) 2004-07-15
AU1988300A (en) 2000-07-31
WO2000039285A3 (en) 2000-11-16
CA2355468A1 (en) 2000-07-06
JP2002533119A (ja) 2002-10-08
EP1141334A2 (de) 2001-10-10
ATE410516T1 (de) 2008-10-15
WO2000039285A2 (en) 2000-07-06
EP1141334B1 (de) 2008-10-08

Similar Documents

Publication Publication Date Title
PT93910A (pt) Prodesso para a preparacao de uma proteina heterologa mediante secrecao a partir de uma celula
DE60128916D1 (de) Neues, physiologisch aktives peptid und dessen verwendung
EP2330127A3 (de) Kalikrein-hemmende Kunitzdomänenproteine und Nukleinsäuren, die diese codieren
WO2004078777A3 (en) Dipeptidyl-peptidase protected proteins
ATE389724T1 (de) Menschliche dnase i hyperaktive varianten
RU95115239A (ru) Аналог эритропоэтина
WO2004000997A3 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
DE69637155D1 (de) Addressine der schleimhaut und der blutgefässe und ihre verwendung
WO2002050277A3 (en) Protein and nucleic acids encoding same
ATE354638T1 (de) Menschlicher gewebsinhibitor von metalloproteinase-4
ATE209684T1 (de) Dna-sequenzen für matrix-metallproteasen, ihre herstellung und verwendung
EP1978362A3 (de) Cross-Beta-Struktur mit Amyloid-bindenden Proteinen und Verfahren für den Nachweis einer Cross-Beta-Struktur, zur Modulation der Fibrillenbildung von Cross-Beta-Strukturen und Cross-Beta-Struktur-vermittelter Toxizität
ATE549353T1 (de) Aktive varianten des il-18 bindenden proteins und dessen medizinische verwendungen
ATE88500T1 (de) Dna-sequenzen, die fuer proteine mit der biologischen aktivitaet der husi-typi-inhibitoren codieren, gentechnologische verfahren zur herstellung dieser proteine und diese proteine enthaltende arzneimittel.
EP1248847B8 (de) Irak-4 zusammensetzungen und deren verwendungen
ATE277171T1 (de) Ikk-alpha proteine, nukleinsäuren und verfahren
DE50212280D1 (de) Verwendung von hmgb-proteinen und dafür codierenden nukleinsäuren
DE69939707D1 (de) Varianten der humanen glycosylphosphatidylinositol-spezifischen phospholipase d und ihre verwendungen
WO2004042083A3 (en) Nucleic acid ligands and uses therefor
CA2581001A1 (en) Kunitz-type recombinant inhibitor
WO2000065028A3 (en) TGF-α POLYPEPTIDES, FUNCTIONAL FRAGMENTS AND METHODS OF USE THEREFOR
WO2003022998A3 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2003078572A3 (en) Therapeutic polypeptides, nucleic acids encoding same and methods of use
WO2003040329A3 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
DE69712182D1 (de) Peptide und ihre verwendung in der therapie von krankheiten des zöliakie-formenkreises

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee